Literature DB >> 27254277

Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

Katherine A Sutherland, Chris M Parry, Adele McCormick, Anne Kapaata, Fred Lyagoba, Pontiano Kaleebu, Charles F Gilks, Ruth Goodall, Moira Spyer, Cissy Kityo, Deenan Pillay, Ravindra K Gupta.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0137834.].

Entities:  

Year:  2016        PMID： 27254277      PMCID： PMC4890937          DOI： 10.1371/journal.pone.0157094

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The title of this article should include “HIV-1.” The correct title is: Evidence for Reduced HIV-1 Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. The correct citation is: Sutherland KA, Parry CM, McCormick A, Kapaata A, Lyagoba F, Kaleebu P, et al. (2015) Evidence for Reduced HIV-1 Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. PLoS ONE 10(9): e0137834. doi:10.1371/journal.pone.0137834.
  1 in total

1.  Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

Authors:  Katherine A Sutherland; Chris M Parry; Adele McCormick; Anne Kapaata; Fred Lyagoba; Pontiano Kaleebu; Charles F Gilks; Ruth Goodall; Moira Spyer; Cissy Kityo; Deenan Pillay; Ravindra K Gupta
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.